
Midatech Pharma plc MTP
Annual report 2024
added 01-17-2026
Midatech Pharma plc DSO Ratio 2011-2026 | MTP
Annual DSO Ratio Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 204 | 981 | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 981 | 204 | 593 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Adagene
ADAG
|
53.8 | $ 2.81 | -3.61 % | $ 158 M | ||
|
Biogen
BIIB
|
57.9 | $ 176.6 | 0.24 % | $ 25.7 B | ||
|
ANI Pharmaceuticals
ANIP
|
114 | $ 80.99 | -1.23 % | $ 1.56 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
76.7 | $ 340.73 | -0.64 % | $ 183 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.59 | 0.39 % | $ 16.3 M | ||
|
CASI Pharmaceuticals
CASI
|
87.4 | $ 0.99 | -0.01 % | $ 135 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.25 | -0.35 % | $ 7.82 B | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 9.72 | -4.19 % | $ 640 M | ||
|
Cerus Corporation
CERS
|
59.2 | $ 2.25 | -3.02 % | $ 415 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Cellectis S.A.
CLLS
|
94.5 | $ 3.91 | -2.03 % | $ 116 M | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 223.02 | -0.42 % | $ 5 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
44.2 | $ 24.39 | -0.77 % | $ 2.89 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 68.44 | -0.98 % | $ 9.15 B | ||
|
Cardiff Oncology
CRDF
|
284 | $ 1.69 | 4.77 % | $ 80.5 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 4.04 | -1.5 % | $ 8.79 B | ||
|
Amneal Pharmaceuticals
AMRX
|
55.7 | $ 13.91 | -1.45 % | $ 4.3 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B |